CIK 0001625101
- Non-accelerated filer
- Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465696597
- Phone
- +1 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-09 | Levinson Mitchell E. Chief Strategy Officer | Purchase · Warrant (right to buy) | +143 | 143 | ||
| 2022-06-09 | Levinson Mitchell E. Chief Strategy Officer | Purchase · Warrant (right to buy) | +143 | 143 | ||
| 2022-06-09 | UECKER DARRIN Director | Option exercise | +7,365 | 137,376 | ||
| 2022-06-09 | UECKER DARRIN Director | Purchase · Warrant (right to buy) | +7,365 | 7,365 | ||
| 2022-05-19 | Spray Shelley D Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-19 | Spray Shelley D Director | Grant or award · Stock Option (right to buy) | +35,047 | 35,047 | ||
| 2022-05-19 | van den Broek Richard Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-19 | van den Broek Richard Director | Grant or award · Stock Option (right to buy) | +79,206 | 79,206 | ||
| 2022-05-19 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-19 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +116,005 | 116,005 | ||
| 2022-05-19 | Zanganeh Maky Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-19 | Zanganeh Maky Director | Grant or award · Stock Option (right to buy) | +56,075 | 56,075 | ||
| 2022-05-19 | DUGGAN ROBERT W Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-19 | DUGGAN ROBERT W Director | Grant or award · Stock Option (right to buy) | +110,467 | 110,467 | ||
| 2022-02-14 | Danahy Kevin Patrick Chief Commercial Office | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2021-12-14 | GARDINER SANDRA A. CFO & EVP Admin. and Finance | Grant or award · Stock Option (right to buy) | +25,961 | 51,922 | ||
| 2021-11-24 | Spray Shelley D Director | Grant or award · Stock Option (right to buy) | +32,500 | 32,500 | ||
| 2021-10-04 | DEBUONO LAUREEN Director | Grant or award · Stock Option (right to buy) | +32,500 | 32,500 | ||
| 2021-08-19 | Levinson Mitchell E. Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +65,510 | 65,510 | ||
| 2021-06-30 | DUGGAN ROBERT W Director | Purchase | +3,048,780 | $16.40 | $50.0M | 14,708,561 |
Page 16 of 27 · 526 trades